| Baseline chronic comorbidity and mortality in laboratory-confirmed COVID-19 cases: results from the PRECOVID study in Spain B Poblador-Plou, J Carmona-Pírez, I Ioakeim-Skoufa, A Poncel-Falcó, ... International journal of environmental research and public health 17 (14), 5171, 2020 | 103 | 2020 |
| Gender differences in medication use: a drug utilization study based on real world data V Orlando, S Mucherino, I Guarino, F Guerriero, U Trama, E Menditto International journal of environmental research and public health 17 (11), 3926, 2020 | 49 | 2020 |
| Development and validation of a clinical risk score to predict the risk of SARS-CoV-2 infection from administrative data: A population-based cohort study from Italy V Orlando, F Rea, L Savaré, I Guarino, S Mucherino, A Perrella, U Trama, ... PLoS One 16 (1), e0237202, 2021 | 26 | 2021 |
| Drug utilization pattern of antibiotics: the role of age, sex and municipalities in determining variation V Orlando, VM Monetti, A Moreno Juste, V Russo, S Mucherino, U Trama, ... Risk management and healthcare policy, 63-71, 2020 | 25 | 2020 |
| Persistence as a robust indicator of medication adherence-related quality and performance E Menditto, C Cahir, S Malo, I Aguilar-Palacio, M Almada, E Costa, ... International journal of environmental research and public health 18 (9), 4872, 2021 | 20 | 2021 |
| Treatment patterns and medication adherence among newly diagnosed patients with migraine: a drug utilisation study V Orlando, S Mucherino, VM Monetti, U Trama, E Menditto BMJ open 10 (11), e038972, 2020 | 20 | 2020 |
| Drug-utilisation profiles and COVID-19 V Orlando, E Coscioni, I Guarino, S Mucherino, A Perrella, U Trama, ... Scientific Reports 11 (1), 8913, 2021 | 18 | 2021 |
| Comorbidity in an older population with type-2 diabetes mellitus: identification of the characteristics and healthcare utilization of high-cost patients I Guerrero-Fernández de Alba, V Orlando, VM Monetti, S Mucherino, ... Frontiers in Pharmacology 11, 586187, 2020 | 18 | 2020 |
| Comorbidity in an older population with type-2 diabetes mellitus: identification of the characteristics and healthcare utilization of high-cost patients IGF de Alba, V Orlando, VM Monetti, S Mucherino, A Gimeno-Miguel, ... Frontiers in pharmacology 11, 2020 | 16 | 2020 |
| Initial therapy, regimen change, and persistence in a Spanish cohort of newly treated type 2 diabetes patients: a retrospective, observational study using real-world data A Moreno-Juste, B Poblador-Plou, M Aza-Pascual-Salcedo, ... International Journal of Environmental Research and Public Health 17 (10), 3742, 2020 | 11 | 2020 |
| Baseline drug treatments as indicators of increased risk of COVID-19 mortality in Spain and Italy K Bliek-Bueno, S Mucherino, B Poblador-Plou, F González-Rubio, ... International Journal of Environmental Research and Public Health 18 (22), 11786, 2021 | 9 | 2021 |
| Geographical variation in medication prescriptions: a multiregional drug-utilization study V Russo, V Orlando, VM Monetti, F Galimberti, M Casula, E Olmastroni, ... Frontiers in Pharmacology 11, 418, 2020 | 9 | 2020 |
| The effectiveness of interventions to evaluate and reduce healthcare costs of potentially inappropriate prescriptions among the older adults: a systematic review S Mucherino, M Casula, F Galimberti, I Guarino, E Olmastroni, E Tragni, ... International Journal of Environmental Research and Public Health 19 (11), 6724, 2022 | 7 | 2022 |
| Changes in Multimorbidity and Polypharmacy Patterns in Young and Adult Population over a 4-Year Period: A 2011–2015 Comparison Using Real-World Data S Mucherino, A Gimeno-Miguel, J Carmona-Pirez, F Gonzalez-Rubio, ... International Journal of Environmental Research and Public Health 18 (9), 4422, 2021 | 7 | 2021 |
| Mapping the use of Group-Based Trajectory Modelling in medication adherence research: A scoping review protocol CA Walsh, S Mucherino, V Orlando, KE Bennett, E Menditto, C Cahir HRB Open Research 3, 2020 | 5 | 2020 |
| Prescription appropriateness of drugs for peptic ulcer and gastro-esophageal reflux disease: baseline assessment in the LAPTOP-PPI cluster randomized trial I Ardoino, M Casula, G Molari, S Mucherino, V Orlando, E Menditto, ... Frontiers in Pharmacology 13, 803809, 2022 | 4 | 2022 |
| Drug-utilisation profiles and COVID-19: retrospective cohort study in Italy V Orlando, E Coscioni, I Guarino, S Mucherino, A Perrella, U Trama, ... | 4 | 2020 |
| Developing and piloting a communication assessment tool assessing patient perspectives on communication with pharmacists (CAT-Pharm) D Scala, S Mucherino, F Wirth, V Orlando, P Polidori, ME Faggiano, ... International Journal of Clinical Pharmacy 44 (4), 1037-1045, 2022 | 3 | 2022 |
| Italian Translation and Validation of the Original ABC Taxonomy for Medication Adherence S Mucherino, M Maffoni, C Cena, LG Armando, M Guastavigna, V Orlando, ... Healthcare 11 (6), 846, 2023 | 2 | 2023 |
| Cost-effectiveness of treatment optimisation with biomarkers for immunotherapy in solid tumours: a systematic review protocol S Mucherino, V Lorenzoni, V Orlando, I Triulzi, M Del Re, A Capuano, ... BMJ open 11 (9), e048141, 2021 | 2 | 2021 |
